New Orleans, Louisiana
Southcentral, Louisiana
New Orleans, Louisiana
New Orleans, Louisiana, Louisiana
New Orleans, Louisiana
Metairie, Louisiana
Baton Rouge, Louisiana
Slidell, Louisiana
New Orleans, Louisiana
Destrehan, Louisiana
Lafayette, LA, USA
Mandeville, Louisiana
Posted: 14-Nov-23
Location: New Orleans, Louisiana
Type: Residency PGY-1
Job Setting:
Specialty Practice Areas:
Required Education:
Children’s Hospital New Orleans Post Graduate Year 1 (PGY1) pharmacy practice residency helps residents develop the necessary clinical pharmacy skills to help patients in their care. By offering pharmacy residency diverse experiences in a variety of disciplines, our program helps them gain a comprehensive view of pharmaceutical care.
PGY1 Pharmacy Residency at Children’s Hospital New Orleans (CHNO) provides 12 months of training in all aspects of advanced pharmacy practice.
Children’s Hospital New Orleans is a 263-bed, not-for-profit pediatric medical center offering a complete range of healthcare services for children from birth to 21 years. With over 40 pediatric specialties and more than 600 pediatric providers, Children's Hospital is the first and largest full-service hospital exclusively for children in Louisiana and the Gulf South. It is the primary pediatric training site for both LSU and Tulane schools of medicine and residency programs along with fellows in pediatric hematology/oncology. Additionally, the pharmacy department is a practice site for Xavier College of Pharmacy and University of Louisiana Monroe College of Pharmacy.
Applications will be accepted using the Pharmacy Online Residency Centralized Application Service (PhORCAS) website. All applicants must register for the ASHP Resident Matching Program as well as submit an application using the PhORCAS portal.
The deadline for application and all specific requirements for acceptance is Tuesday January 2, 2024. Interested applicants should have a PharmD, be eligible for Louisiana Licensure and a Louisiana intern license, and submit the standardized application materials through PhORCAS.
This program is accredited by the American Society of Health-System Pharmacists – the organization responsible for accreditation of such programs. Their guidance helps to formulate and recommend changes in standards, assess compliance of standards, and recommend accreditation for programs.
The materials that must be submitted to PhORCAS by the first Tuesday January 2, 2024 include:
- Letter of intent that includes why you chose to apply to the residency program
- Curriculum vitae
- Three letters of recommendation – a minimum of one of your three references should come from a preceptor who you have worked with in a clinical setting, related to an APPE in acute or ambulatory care. The clinical preceptor should be able to comment on your scope of responsibility, total patient load, level or autonomy, clinical abilities, and organization and time management skills. All 3 reference writers should use the standard PhORCAS template to submit their candidate recommendation and comment on a minimum of 7 or the 13 listed candidate characteristics.
- A response to an essay statement is required for acceptance. The essay response should be no longer than one page in length. An application will not be reviewed if this statement is missing. Please note that the essay is separate from your cover letter.
- Official pharmacy school transcripts
Supplemental essay question requirements:
Describe an intervention or contribution that you made with significant impact on patient care. Discuss what you learned from your experience.
Provide a response to the question above using Calibri Font, size 11, double spaced, using normal margins. Your answer should be no more than 1 page in length.
NOTE: The essay response should be uploaded in the Supplemental Information section in PhORCAS. Space is limited to a max of 5 MB and must be provided in the following format: .pdf, .doc, .txt, .rtf.